Back to Journals » Psoriasis: Targets and Therapy » Volume 8
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,642 | Dovepress* | 9,313+ | 1,376 | 10,689 | |
PubMed Central* | 2,329 | 418 | 2,747 | ||
Totals | 11,642 | 1,794 | 13,436 | ||
*Since 29 August 2018 |
View citations on PubMed Central and Google Scholar